Industry: Service & Software
Published Date: 2026-07-14
Pages: 105 Pages
Report ld: 6916347
Request Sample
Customized Report
Metagenomics Next Generation Sequencing Market Size(US$)

CAGR 2026-2032
5.9%
Market Size,2032
USD 539
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Metagenomics Next Generation Sequencing was estimated to be worth US$ 363 million in 2025 and is projected to reach US$ 539 million, growing at a CAGR of 5.9% from 2026 to 2032.
Metagenome is the sum of the genetic material of all tiny organisms in the habitat. It contains the genes of culturable and non-culturable microorganisms, and currently mainly refers to the total genome of bacteria and fungi in environmental samples.
The North American market for Metagenomics Next Generation Sequencing was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Metagenomics Next Generation Sequencing was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Metagenomics Next Generation Sequencing was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Metagenomics Next Generation Sequencing market include Sigma-Aldrich, Genskey Technologies Co. Ltd., Biomarker, Thermo Fisher Illumina, Sangon Biotech (Shanghai) Co., Ltd., BGI Genomics, NCIMB, Qiagen, Baseclear, Genewiz, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Metagenomics Next Generation Sequencing, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Metagenomics Next Generation Sequencing market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Metagenomics Next Generation Sequencing.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Metagenomics Next Generation Sequencing companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Metagenomics Next Generation Sequencing revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Metagenomics Next Generation Sequencing revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Metagenomics Next Generation Sequencing Product Introduction
1.2 Global Metagenomics Next Generation Sequencing Market Size Forecast (2021–2032)
1.3 Metagenomics Next Generation Sequencing Market Trends & Drivers
1.3.1 Metagenomics Next Generation Sequencing Industry Trends
1.3.2 Metagenomics Next Generation Sequencing Market Drivers & Opportunities
1.3.3 Metagenomics Next Generation Sequencing Market Challenges
1.3.4 Metagenomics Next Generation Sequencing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Metagenomics Next Generation Sequencing Players Revenue Ranking (2025)
2.2 Global Metagenomics Next Generation Sequencing Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Metagenomics Next Generation Sequencing Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Metagenomics Next Generation Sequencing
2.6 Metagenomics Next Generation Sequencing Market Competitive Analysis
2.6.1 Metagenomics Next Generation Sequencing Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Metagenomics Next Generation Sequencing Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Metagenomics Next Generation Sequencing revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Metagenomics Next Generation Sequencing Market Classification
3.1 Introduction by Type
3.1.1 Sample Processing Service
3.1.2 Sequencing Service
3.1.3 Data Analysis Service
3.1.4 Global Metagenomics Next Generation Sequencing Sales Value by Type
3.1.4.1 Global Metagenomics Next Generation Sequencing Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Metagenomics Next Generation Sequencing Sales Value, by Type (2021–2032)
3.1.4.3 Global Metagenomics Next Generation Sequencing Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Microbiology Research
4.1.2 Environmental Science
4.1.3 Others
4.2 Global Metagenomics Next Generation Sequencing Sales Value by Application
4.2.1 Global Metagenomics Next Generation Sequencing Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Metagenomics Next Generation Sequencing Sales Value by Application (2021–2032)
4.2.3 Global Metagenomics Next Generation Sequencing Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Metagenomics Next Generation Sequencing Sales Value by Region
5.1.1 Global Metagenomics Next Generation Sequencing Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Metagenomics Next Generation Sequencing Sales Value by Region (2021–2026)
5.1.3 Global Metagenomics Next Generation Sequencing Sales Value by Region (2027–2032)
5.1.4 Global Metagenomics Next Generation Sequencing Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Metagenomics Next Generation Sequencing Sales Value, 2021–2032
5.2.2 North America Metagenomics Next Generation Sequencing Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Metagenomics Next Generation Sequencing Sales Value, 2021–2032
5.3.2 Europe Metagenomics Next Generation Sequencing Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Metagenomics Next Generation Sequencing Sales Value, 2021–2032
5.4.2 Asia Pacific Metagenomics Next Generation Sequencing Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Metagenomics Next Generation Sequencing Sales Value, 2021–2032
5.5.2 South America Metagenomics Next Generation Sequencing Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Metagenomics Next Generation Sequencing Sales Value, 2021–2032
5.6.2 Middle East & Africa Metagenomics Next Generation Sequencing Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Metagenomics Next Generation Sequencing Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Metagenomics Next Generation Sequencing Sales Value, 2021–2032
6.3 United States
6.3.1 United States Metagenomics Next Generation Sequencing Sales Value, 2021–2032
6.3.2 United States Metagenomics Next Generation Sequencing Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Metagenomics Next Generation Sequencing Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Metagenomics Next Generation Sequencing Sales Value, 2021–2032
6.4.2 Europe Metagenomics Next Generation Sequencing Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Metagenomics Next Generation Sequencing Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Metagenomics Next Generation Sequencing Sales Value, 2021–2032
6.5.2 China Metagenomics Next Generation Sequencing Sales Value by Type (%), 2025 vs 2032
6.5.3 China Metagenomics Next Generation Sequencing Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Metagenomics Next Generation Sequencing Sales Value, 2021–2032
6.6.2 Japan Metagenomics Next Generation Sequencing Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Metagenomics Next Generation Sequencing Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Metagenomics Next Generation Sequencing Sales Value, 2021–2032
6.7.2 South Korea Metagenomics Next Generation Sequencing Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Metagenomics Next Generation Sequencing Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Metagenomics Next Generation Sequencing Sales Value, 2021–2032
6.8.2 Southeast Asia Metagenomics Next Generation Sequencing Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Metagenomics Next Generation Sequencing Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Metagenomics Next Generation Sequencing Sales Value, 2021–2032
6.9.2 India Metagenomics Next Generation Sequencing Sales Value by Type (%), 2025 vs 2032
6.9.3 India Metagenomics Next Generation Sequencing Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Sigma-Aldrich
7.1.1 Sigma-Aldrich Profile
7.1.2 Sigma-Aldrich Main Business
7.1.3 Sigma-Aldrich Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.1.4 Sigma-Aldrich Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.1.5 Sigma-Aldrich Recent Developments
7.2 Genskey Technologies Co. Ltd.
7.2.1 Genskey Technologies Co. Ltd. Profile
7.2.2 Genskey Technologies Co. Ltd. Main Business
7.2.3 Genskey Technologies Co. Ltd. Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.2.4 Genskey Technologies Co. Ltd. Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.2.5 Genskey Technologies Co. Ltd. Recent Developments
7.3 Biomarker
7.3.1 Biomarker Profile
7.3.2 Biomarker Main Business
7.3.3 Biomarker Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.3.4 Biomarker Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.3.5 Biomarker Recent Developments
7.4 Thermo Fisher Illumina
7.4.1 Thermo Fisher Illumina Profile
7.4.2 Thermo Fisher Illumina Main Business
7.4.3 Thermo Fisher Illumina Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.4.4 Thermo Fisher Illumina Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.4.5 Thermo Fisher Illumina Recent Developments
7.5 Sangon Biotech (Shanghai) Co., Ltd.
7.5.1 Sangon Biotech (Shanghai) Co., Ltd. Profile
7.5.2 Sangon Biotech (Shanghai) Co., Ltd. Main Business
7.5.3 Sangon Biotech (Shanghai) Co., Ltd. Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.5.4 Sangon Biotech (Shanghai) Co., Ltd. Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.5.5 Sangon Biotech (Shanghai) Co., Ltd. Recent Developments
7.6 BGI Genomics
7.6.1 BGI Genomics Profile
7.6.2 BGI Genomics Main Business
7.6.3 BGI Genomics Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.6.4 BGI Genomics Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.6.5 BGI Genomics Recent Developments
7.7 NCIMB
7.7.1 NCIMB Profile
7.7.2 NCIMB Main Business
7.7.3 NCIMB Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.7.4 NCIMB Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.7.5 NCIMB Recent Developments
7.8 Qiagen
7.8.1 Qiagen Profile
7.8.2 Qiagen Main Business
7.8.3 Qiagen Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.8.4 Qiagen Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.8.5 Qiagen Recent Developments
7.9 Baseclear
7.9.1 Baseclear Profile
7.9.2 Baseclear Main Business
7.9.3 Baseclear Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.9.4 Baseclear Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.9.5 Baseclear Recent Developments
7.10 Genewiz
7.10.1 Genewiz Profile
7.10.2 Genewiz Main Business
7.10.3 Genewiz Metagenomics Next Generation Sequencing Products, Services, and Solutions
7.10.4 Genewiz Metagenomics Next Generation Sequencing Revenue (US$ Million), 2021–2026
7.10.5 Genewiz Recent Developments
8 Industry Chain Analysis
8.1 Metagenomics Next Generation Sequencing Value Chain
8.2 Metagenomics Next Generation Sequencing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Metagenomics Next Generation Sequencing Sales Model
8.5.2 Sales Channels
8.5.3 Metagenomics Next Generation Sequencing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Metagenomics Next Generation Sequencing market was valued at US$ 363 million in 2025 and is anticipated to reach US$ 539 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 105
USD 2900.00
(Single User License)
The global Metagenomics Next Generation Sequencing market is projected to grow from US$ 344 million in 2024 to US$ 512 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 116
USD 4900.00
(Single User License)
The global Metagenomics Next Generation Sequencing market size was US$ 344 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 78
USD 4250.00
(Single User License)
The global market for Metagenomics Next Generation Sequencing was estimated to be worth US$ 344 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 91
USD 3950.00
(Single User License)
The global market for Metagenomics Next Generation Sequencing was valued at US$ 344 million in the year 2024 and is projected to reach a revised size of US$ 512 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-02-20
Pages: 71
USD 2900.00
(Single User License)
Metagenome is the sum of the genetic material of all tiny organisms in the habitat. It contains the genes of culturable and non-culturable microorganisms, and currently mainly refers to the total genome of bacteria and fungi in environmental samples.
Published Date: 2024-04-07
Pages: 113
USD 4900.00
(Single User License)
Metagenome is the sum of the genetic material of all tiny organisms in the habitat. It contains the genes of culturable and non-culturable microorganisms, and currently mainly refers to the total genome of bacteria and fungi in environmental samples.
Published Date: 2024-02-19
Pages: 108
USD 3950.00
(Single User License)
Metagenome is the sum of the genetic material of all tiny organisms in the habitat. It contains the genes of culturable and non-culturable microorganisms, and currently mainly refers to the total genome of bacteria and fungi in environmental samples.
Published Date: 2024-01-12
Pages: 81
USD 2900.00
(Single User License)
The global Metagenomics Next Generation Sequencing market was valued at US$ 363 million in 2025 and is anticipated to reach US$ 539 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-21
Pages: 105
The global Metagenomics Next Generation Sequencing market is projected to grow from US$ 344 million in 2024 to US$ 512 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 116
The global Metagenomics Next Generation Sequencing market size was US$ 344 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 78
The global market for Metagenomics Next Generation Sequencing was estimated to be worth US$ 344 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 91
The global market for Metagenomics Next Generation Sequencing was valued at US$ 344 million in the year 2024 and is projected to reach a revised size of US$ 512 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-02-20
Pages: 71
Metagenome is the sum of the genetic material of all tiny organisms in the habitat. It contains the genes of culturable and non-culturable microorganisms, and currently mainly refers to the total genome of bacteria and fungi in environmental samples.
Published: 2024-04-07
Pages: 113
Metagenome is the sum of the genetic material of all tiny organisms in the habitat. It contains the genes of culturable and non-culturable microorganisms, and currently mainly refers to the total genome of bacteria and fungi in environmental samples.
Published: 2024-02-19
Pages: 108
Metagenome is the sum of the genetic material of all tiny organisms in the habitat. It contains the genes of culturable and non-culturable microorganisms, and currently mainly refers to the total genome of bacteria and fungi in environmental samples.
Published: 2024-01-12
Pages: 81
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now